US 7098330
Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
granted A61PA61P1/16A61P11/06
Quick answer
US patent 7098330 (Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/16, A61P11/06, A61P17/06, A61P19/00